Hepatitis C Virus
Study results from I.S. Elefsiniotis and colleagues broaden understanding of hepatitis C virus
Published in Hepatitis Weekly, July 28th, 2008
"The aim of this study was to investigate the effect of patient's age on the impact of typically proposed predictors of sustained virological response (SVR) in treatment-naive, high-pretreatment viral load (> 700.000 IU/ml), chronic hepatitis C (CHC) patients treated under real-life conditions in Greece. We retrospectively analyzed 185 CHC patients (14.4% cirrhotics) who had been treated with weight-adjusted dosing (1.5 mu g/kg per week) of pegylated interferon-a2b (PEG) plus genotype-based ribavirin (RIB) for 24 or 48 weeks of treatment, based on viral genotype," scientists in Greece report.
"SVR was confirmed by undetectable serum HCV-RNA 6 months after the end of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-07-28)
More Articles from Hepatitis Weekly
- Universidad de Granada
Stem cells from umbilical cord used in the treatment of hepatic diseases - University of California - San Diego
Improved culture system for hepatitis C virus infection - Acute Hepatitis
Reports by Z. Zhang and co-researchers describe recent advances in acute hepatitis - Acute Hepatitis
Research from University of Delhi in acute hepatitis provides new insights - Alcoholism
Research from E. Ishibashi and colleagues provide new insights into alcoholism - Breast Cancer
Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008 - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
